NCT00940225 Study of Cabozantinib (XL184) in Adults With Advanced Malignancies Status COMPLETED Phase PHASE2
NCT00937664 Safety and Tolerability Study of AZD7762 in Combination With Gemcitabine Status TERMINATED Phase PHASE1
NCT00925275 Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00921869 A Study of E7050 Administered Orally to Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00918320 Studies of Temozolomide in Combination With Topotecan in Refractory and Relapsed Paediatric Solid Tumours Status COMPLETED Phase PHASE2
NCT00918281 Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection Status COMPLETED Phase PHASE2
NCT00909207 Patient-Reported Outcomes Version of Common Terminology Criteria (CTCPRO) Cognitive Debriefing Status COMPLETED Phase N/A
NCT00909025 Safety and Tolerability Study of Claudiximab in Patients With Advanced Gastroesophageal Cancer Status COMPLETED Phase PHASE1
NCT00900497 A Study Using White Blood Cells From Healthy Donors To Treat Solid Cancers Status ENROLLING_BY_INVITATION Phase PHASE1/PHASE2
NCT00894894 Safety Study to Determine the Maximum Tolerated Dose, Pharmacokinetics and Pharmacodynamics of Oral MP470, a Multitargeted Tyrosine Kinase Inhibitor, in Patients With Solid Malignancies Status COMPLETED Phase PHASE1
NCT00891605 Safety Study of ABT-263 in Combination With Paclitaxel in Subjects With Solid Tumors Status COMPLETED Phase PHASE1
NCT00889382 A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors) Status COMPLETED Phase PHASE1/PHASE2
NCT00888043 Safety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors Status COMPLETED Phase PHASE1
NCT00887757 Safety Study of ABT-263 in Combination With Gemzar (Gemcitabine) in Subjects With Solid Tumors Status COMPLETED Phase PHASE1
NCT00884312 A Study of Extended Carfilzomib Therapy for Patients Previously Enrolled in Carfilzomib Treatment Protocols Status COMPLETED Phase PHASE2
NCT00882180 Dose Escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous ALN-VSP02 In Patients With Advanced Solid Tumors With Liver Involvement Status COMPLETED Phase PHASE1
NCT00878449 A Study Evaluating the Safety of ABT-263 in Combination With Etoposide/Cisplatin in Subjects With Cancer Status COMPLETED Phase PHASE1
NCT00878111 Study of NGR-hTNF Administered at High Doses in Patient With Advanced or Metastatic Solid Tumour Status COMPLETED Phase PHASE1
NCT00871910 Phase 1 Every-3-Week Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04630) Status COMPLETED Phase PHASE1
NCT00871663 Phase 1 Weekly Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04629AM6) Status COMPLETED Phase PHASE1